Strongbridge Biopharma plc SBBP
2.00 +2.00
Day range unavailable
52-week range unavailable
News
businesswire.com Xeris Pharmaceuticals Completes Acquisition of Strongbridge Biopharma CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (“Xeris”), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable…
globenewswire.com Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc. DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the…
globenewswire.com Strongbridge Biopharma plc Announces Court Hearing Date to Approve Proposed Acquisition by Xeris Pharmaceuticals, Inc. DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the…
globenewswire.com Strongbridge Biopharma plc Announces Shareholder Approval of Proposed Acquisition by Xeris Pharmaceuticals, Inc. DUBLIN, Ireland and TREVOSE, Pa., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that its shareholders have voted to…
globenewswire.com Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris Glass Lewis Joins ISS in Recommending Strongbridge Shareholders Vote “FOR” Transaction with Xeris
globenewswire.com Leading Independent Proxy Advisory Firm ISS Recommends Strongbridge Biopharma plc Shareholders Vote “FOR” the Transaction With Xeris Strongbridge Urges Shareholders to Vote “FOR” All Transaction-Related Proposals Strongbridge Urges Shareholders to Vote “FOR” All Transaction-Related Proposals
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday morning, 207 companies hit new 52-week lows.
zacks.com Strongbridge Biopharma (SBBP) Reports Q2 Loss, Tops Revenue Estimates Strongbridge Biopharma (SBBP) delivered earnings and revenue surprises of 20.00% and 13.69%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
globenewswire.com Strongbridge Biopharma plc Reports Second Quarter 2021 Financial Results and Provides Corporate Update ~ Reports KEVEYIS ® (dichlorphenamide) Second Quarter 2021 Revenue of $10.0 Million, a 28 Percent Increase Compared to $7.8 Million of Revenue During Second Quarter of 2020 ~
benzinga.com Earnings Scheduled For August 5, 2021 Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.
globenewswire.com Strongbridge Biopharma plc Announces Commencement of Mailing of Proxy Statement DUBLIN, Ireland and TREVOSE, Pa., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP) (“Strongbridge”), a global commercial-stage biopharmaceutical company focused on the…
globenewswire.com Strongbridge Biopharma plc Provides Announcement Under the Irish Takeover Rules for Relevant Securities in Issue DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP) (“Strongbridge”), a global commercial-stage biopharmaceutical company focused on the…
globenewswire.com Strongbridge Biopharma plc to Report Second Quarter 2021 Financial Results on August 5, 2021 DUBLIN, Ireland and TREVOSE, Pa., July 29, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and…
zacks.com Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release Strongbridge Biopharma (SBBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
globenewswire.com Strongbridge Biopharma plc Announces Publication of Long-term Efficacy and Safety Results for KEVEYIS® (dichlorphenamide) for the Treatment of Primary Periodic Paralysis in Muscle & Nerve ~ Study Confirms Long-Term Treatment with KEVEYIS is Safe and Effective for Chronic Use ~
globenewswire.com Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing's Syndrome DUBLIN, Ireland and TREVOSE, Pa., June 03, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and…
prnewswire.com SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Strongbridge Biopharma plc - SBBP NEW YORK, May 29, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class…
businesswire.com STRONGBRIDGE BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Strongbridge Biopharma plc - SBBP NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Strongbridge…
businesswire.com Strongbridge Biopharma Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Strongbridge Biopharma plc Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – SBBP NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Strongbridge Biopharma plc (NASDAQ: SBBP) to Xeris Pharmaceuticals, Inc. is fair…
prnewswire.com SHAREHOLDER ALERT: WeissLaw LLP Investigates Strongbridge Biopharma plc NEW YORK, May 24, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Strongbridge Biopharma plc…
benzinga.com Earnings Scheduled For May 12, 2021 Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.
benzinga.com Earnings Scheduled For March 3, 2021 Companies Reporting Before The Bell • Brown Forman Inc Class A Common Stock (NYSE:BF) is likely to report earnings for its third quarter.- benzinga.com Earnings Scheduled For October 29, 2020 Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings at $0.27 per share on revenue of $4.72 billion.
benzinga.com 75 Biggest Movers From Friday Gainers Forma Therapeutics Holdings, Inc. (NASDAQ: FMTX) shares rose 95% to close at $39.00 on Friday after the company priced its IPO at $20 per share.
benzinga.com Stocks That Hit 52-Week Highs On Friday Friday's morning session saw 144 companies set new 52-week highs.- benzinga.com 98 Biggest Movers From Friday Gainers Liberty Global plc (NASDAQ: LBTYB) shares climbed 66.7% to close at $32.00 on Friday. Telefonica is seeking to merge its British mobile operator O2 and Liberty's Virgin Media cable network…
- benzinga.com 77 Biggest Movers From Yesterday
benzinga.com 55 Stocks Moving In Monday's Mid-Day Session 
benzinga.com Stocks That Hit 52-Week Lows On Monday - benzinga.com Stocks That Hit 52-Week Lows On Thursday
- benzinga.com 70 Biggest Movers From Yesterday
- benzinga.com New 52-Week Lows For Monday Morning
- benzinga.com List of Companies Reaching Yearly Lows Tuesday
benzinga.com 60 Biggest Movers From Yesterday - benzinga.com 52 Biggest Movers From Yesterday
benzinga.com 41 Stocks Moving In Monday's Mid-Day Session - benzinga.com Benzinga's Top Upgrades, Downgrades For December 18, 2018
- benzinga.com 82 Biggest Movers From Yesterday
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, September 17th
- benzinga.com Stocks Which Set New 52-Week Low Friday, September 14
- benzinga.com Stocks Which Set New 52-Week Low Yesterday, August 7th
- benzinga.com Stocks Which Set New 52-Week Low Friday, July 27